Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,010,075
  • Shares Outstanding, K 682,483
  • Annual Sales, $ 863,500 K
  • Annual Income, $ -188,860 K
  • EBIT $ -104 M
  • EBITDA $ 2 M
  • 60-Month Beta 1.63
  • Price/Sales 1.48
  • Price/Cash Flow N/A
  • Price/Book 0.75

Options Overview Details

View History
  • Implied Volatility 79.26% ( +8.84%)
  • Historical Volatility 31.10%
  • IV Percentile 56%
  • IV Rank 33.90%
  • IV High 213.50% on 07/30/24
  • IV Low 10.42% on 06/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1,537
  • Volume Avg (30-Day) 2,435
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 367,659
  • Open Int (30-Day) 426,823

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.09
  • Number of Estimates 5
  • High Estimate -0.03
  • Low Estimate -0.15
  • Prior Year -0.09
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4300 +3.50%
on 12/30/24
1.7600 -15.91%
on 12/12/24
-0.1100 (-6.92%)
since 12/06/24
3-Month
1.3700 +8.03%
on 11/07/24
1.7600 -15.91%
on 12/12/24
+0.0100 (+0.68%)
since 10/08/24
52-Week
0.8601 +72.07%
on 03/19/24
1.7600 -15.91%
on 12/12/24
+0.4800 (+48.00%)
since 01/08/24

Most Recent Stories

More News
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

OPK : 1.4800 (-1.99%)
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

OPK : 1.4800 (-1.99%)
3 Stocks That Wall Street Insiders Can’t Stop Buying

Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.

VSTS : 16.34 (-0.67%)
GEF : 59.66 (+0.29%)
OPK : 1.4800 (-1.99%)
CTAS : 192.65 (+2.08%)
UNF : 214.48 (+4.78%)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 500,000 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 500,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.4800 (-1.99%)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 199,072 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 199,072 shares of the company on 11-29-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.4800 (-1.99%)
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

OPK : 1.4800 (-1.99%)
Opko Health (OPK) Q3 2024 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2024.

OPK : 1.4800 (-1.99%)
OPKO Health: Q3 Earnings Snapshot

OPKO Health: Q3 Earnings Snapshot

OPK : 1.4800 (-1.99%)
OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

OPK : 1.4800 (-1.99%)
OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

OPK : 1.4800 (-1.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.5617
2nd Resistance Point 1.5333
1st Resistance Point 1.5067
Last Price 1.4800
1st Support Level 1.4517
2nd Support Level 1.4233
3rd Support Level 1.3967

See More

52-Week High 1.7600
Last Price 1.4800
Fibonacci 61.8% 1.4162
Fibonacci 50% 1.3101
Fibonacci 38.2% 1.2039
52-Week Low 0.8601

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar